Published in Stroke on December 09, 2010
Minocycline prevents IL-6 increase after acute ischemic stroke. Transl Stroke Res (2012) 0.79
Ischemic stroke subtypes and risk factors: the probable bias arisen from the classification style across studies. Stroke (2010) 0.75
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood (2006) 8.33
Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology (2012) 3.04
Gallstone ileus analysis of radiological findings in 27 patients. Eur J Radiol (2004) 2.52
The role of the EGFR signaling in tumor microenvironment. J Cell Physiol (2008) 2.34
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J (2003) 2.10
Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med (2009) 1.82
Gastro-duodenal perforations: conventional plain film, US and CT findings in 166 consecutive patients. Eur J Radiol (2004) 1.81
Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol (2005) 1.74
Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost (2009) 1.67
Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail (2009) 1.64
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum (2003) 1.62
Arterial stiffness indexes in acute ischemic stroke: relationship with stroke subtype. Atherosclerosis (2010) 1.61
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med (2011) 1.59
Three-dimensional reconstruction of tarantula myosin filaments suggests how phosphorylation may regulate myosin activity. J Mol Biol (2008) 1.59
Supraventricular tachycardias: proposal of a diagnostic algorithm for the narrow complex tachycardias. J Cardiol (2013) 1.58
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol (2010) 1.55
Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des (2008) 1.54
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol (2011) 1.50
An uncommon clinical picture: Wellens' syndrome in a morbidly obese young man. Intern Emerg Med (2010) 1.47
Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2014) 1.45
Association between low education and higher global cardiovascular risk. J Clin Hypertens (Greenwich) (2015) 1.42
Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. Clin Rheumatol (2007) 1.38
Atherosclerosis as an inflammatory disease. Curr Pharm Des (2012) 1.31
Role of Spiral and Multislice Computed Tomography in the evaluation of traumatic and spontaneous oesophageal perforation. Our experience. Radiol Med (2005) 1.29
Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer (2004) 1.27
Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem (2009) 1.21
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma. Br J Haematol (2011) 1.20
Photoinduced CO release, cellular uptake and cytotoxicity of a tris(pyrazolyl)methane (tpm) manganese tricarbonyl complex. Chem Commun (Camb) (2008) 1.17
Inflammation in ischemic stroke subtypes. Curr Pharm Des (2012) 1.13
Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. Atherosclerosis (2012) 1.12
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. J Am Med Inform Assoc (2006) 1.11
5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? Blood (2003) 1.10
Accuracy of ultrasonography in the diagnosis of acute appendicitis in adult patients: review of the literature. Crit Ultrasound J (2013) 1.08
Neurological complications of Anderson-Fabry disease. Curr Pharm Des (2013) 1.06
Anderson-Fabry disease: a multiorgan disease. Curr Pharm Des (2013) 1.04
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Int J Cancer (2008) 1.04
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine (2012) 1.04
High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr (2010) 1.03
Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis (2007) 1.02
Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem (2009) 1.02
Body packing: a review of general background, clinical and imaging aspects. Radiol Med (2014) 1.02
Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol (2012) 1.01
A molecular model of phosphorylation-based activation and potentiation of tarantula muscle thick filaments. J Mol Biol (2011) 1.00
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J Hematol (2006) 1.00
Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era. Intern Emerg Med (2008) 0.98
Esophageal injuries: spectrum of multidetector row CT findings. Eur J Radiol (2006) 0.97
Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol (2010) 0.97
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. Diabetol Metab Syndr (2014) 0.97
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer (2009) 0.96
Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med (2011) 0.95
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol (2011) 0.94
Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study. Intern Emerg Med (2012) 0.94
Visceral obesity and metabolic syndrome: two faces of the same medal? Intern Emerg Med (2009) 0.94
[Positive predictive value and negative predictive value of spiral CT in the diagnosis of closed loop obstruction complicated by intestinal ischemia]. Radiol Med (2004) 0.93
A deadly organometallic luminescent probe: anticancer activity of a ReI bisquinoline complex. Chemistry (2014) 0.93
Genistein in the metabolic syndrome: results of a randomized clinical trial. J Clin Endocrinol Metab (2013) 0.93
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond) (2009) 0.92
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma. Am J Hematol (2010) 0.91
Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med (2004) 0.91
Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study. Int J Cardiol (2010) 0.91
Determining optimum management of descending necrotizing mediastinitis with CT; experience with 32 cases. Emerg Radiol (2005) 0.91
Transcatheter embolisation of iatrogenic renal vascular injuries. Radiol Med (2013) 0.91
Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis (2010) 0.90
Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma (2004) 0.90
Synthesis, characterisation and bioimaging of a fluorescent rhenium-containing PNA bioconjugate. Dalton Trans (2011) 0.90
Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma. Leuk Lymphoma (2007) 0.89
Multi-detector row computed tomography and blunt chest trauma. Eur J Radiol (2007) 0.89
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. Blood (2011) 0.89
Vascular Effects of Progesterone : Role of Cellular Calcium Regulation. Hypertension (2001) 0.89
Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism (2008) 0.89
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. PLoS One (2013) 0.88